Results for tag: "Allopregnanolone"

Allopregnanolone is a neurosteroid drug used in the treatment of central nervous system (CNS) disorders. It is a synthetic form of the naturally occurring hormone progesterone and is believed to act as a positive allosteric modulator of the GABA-A receptor. Allopregnanolone has been studied for its potential to treat a variety of CNS disorders, including anxiety, depression, epilepsy, and post-traumatic stress disorder (PTSD). It has also been studied for its potential to improve cognitive function and reduce the risk of Alzheimer's disease. Allopregnanolone is available in both oral and injectable forms, and is typically prescribed in combination with other medications. It is generally well-tolerated, with few reported side effects. The Allopregnanolone market is a rapidly growing segment of the CNS drugs market. It is expected to continue to grow as more research is conducted into its potential therapeutic benefits. Some companies in the Allopregnanolone market include AbbVie, Allergan, Merck, Pfizer, and Teva Pharmaceuticals. Show Less Read more